Aakash group moves to healthcare, to invests Rs 220 cr for hospitals foray

Published On 2016-11-20 03:45 GMT   |   Update On 2016-11-20 03:45 GMT
Aakash Healthcare is foraying into the hospitals segment and has invested around Rs 220 crore to launch its first super speciality hospital in Delhi by January 2017.

"We are entering the hospitals segment with the launch of our 230 bed super-speciality hospital in Delhi by January 2017. We have invested around Rs 220 crore for the facility," Aakash Healthcare Pvt Ltd Director Aashish Chaudhry told .

Aakash Healthcare is part of the Aakash Group, which runs education centres across the country.

Apart from other specialities, the focus is on cardiac care, neurosciences, mother and child, nephrology, opthalmology and orthopaedics, among others, Chaudhry added.

Asked about the investment break-up for the hospital, Chaudhry said: "Out of the total investment, Rs 70 crore is equity while rest is loans from banks."

The company is also looking to open four more hospitals in the next four years.

"The aim is to open 4 four more hospitals by 2020 end. But these will be smaller hospitals. They will be single speciality surgical hospitals or boutique hospitals, with say focus on mother and child," Chaudhry said.

Investment on the four hospitals will be between Rs 400 crore and Rs 500 crore. For these, the company will be focusing on tier II cities which do not have quality care facilities, he added. AKT ABM
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News